Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Borregaard ASA ( (GB:0QB7) ) has provided an update.
Borregaard ASA has announced the appointment of Knut-Harald Bakke as the new Executive Vice President of BioSolutions, effective August 1, 2025. Bakke, who currently serves as Director of Investor Relations, will also join the Group Executive Management. This leadership change is part of a broader transition as Tom Erik Foss-Jacobsen steps into the CEO role. The company will begin searching for a new Director of Investor Relations, with CFO Per Bjarne Lyngstad temporarily assuming the role. These changes are expected to impact Borregaard’s strategic direction and operational focus in the bio-based solutions sector.
The most recent analyst rating on (GB:0QB7) stock is a Buy with a NOK210.00 price target. To see the full list of analyst forecasts on Borregaard ASA stock, see the GB:0QB7 Stock Forecast page.
More about Borregaard ASA
Borregaard ASA operates in the bio-based solutions industry, focusing on the development and production of sustainable biochemicals and biomaterials. The company is known for its innovative approach to utilizing natural raw materials to create products that serve various markets, including agriculture, construction, and pharmaceuticals.
Average Trading Volume: 81,732
Current Market Cap: NOK19B
For an in-depth examination of 0QB7 stock, go to TipRanks’ Overview page.